Skip to main content
OpenTrials

Clinical trial condition

Esophageal Cancer

Explore clinical trials studying Esophageal Cancer. Study availability and eligibility vary by location and protocol.

737 public trials 183 recruiting studies
Refine in advanced search Browse all conditions

Esophageal Cancer trial results

Recruiting

DESTINY-PANTUMOUR04

NCT07124000

Conditions
Adenocarcinoma, Adenocarcinoma (NOS), Adnexal Diseases, +116 more
Locations
  • Research Site Birmingham, Alabama, United States
  • Research Site Bullhead City, Arizona, United States
  • Research Site Casa Grande, Arizona, United States
  • Research Site San Diego, California, United States
View all 18 locations
View Trial Details
Recruiting

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

NCT06172478

Conditions
Adnexal Diseases, Advanced Solid Tumor, Bladder Cancer, +70 more
Locations
  • City of Hope Duarte, California, United States
  • Yale Cancer Center New Haven, Connecticut, United States
  • AdventHealth Medical Group Oncology Research at Celebration Kissimmee, Florida, United States
  • University of Illinois Cancer Center Chicago, Illinois, United States
View all 91 locations
View Trial Details
Recruiting

A Study of Pembrolizumab With Trastuzumab and Chemotherapy in People With Esophagogastric Cancer

NCT06123338

Conditions
Digestive System Diseases, Digestive System Neoplasms, Esophageal Cancer, +9 more
Locations
  • Massachusetts General Hospital (Data Collection Only) Boston, Massachusetts, United States
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
View Trial Details
Recruiting

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

NCT06047379

Conditions
Adenocarcinoma, Astrocytoma, Brain Diseases, +93 more
Locations
  • Precision NextGen Oncology Beverly Hills, California, United States
  • OPN Healthcare, Inc Glendale, California, United States
  • University of Southern California Los Angeles, California, United States
  • MDR Core Network Boynton Beach, Florida, United States
View Trial Details
Recruiting

Pan-tumor MRD Study

NCT06605404

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +34 more
Locations
  • Medical Oncology Associates of San Diego San Diego, California, United States
  • Taylor Cancer Research Center Maumee, Ohio, United States
  • Alabama Oncology Birmingham, Alabama, United States
  • Mohtaseb Cancer Center and Blood Disorders Bullhead City, Arizona, United States
View all 47 locations
View Trial Details
Recruiting

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

NCT05983432

Conditions
Adnexal Diseases, Breast Diseases, Breast Neoplasms, +60 more
Locations
  • Beverly Hills Cancer Center Beverly Hills, California, United States
  • City of Hope Cancer Center Duarte, California, United States
  • University of California Irvine Medical Center Orange, California, United States
  • UCLA Santa Monica Santa Monica, California, United States
View all 37 locations
View Trial Details
Recruiting

A Phase 1 Study of IM-1617 in Participants With Advanced Cancer

NCT07578571

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +31 more
Locations
  • Florida Cancer Specialists & Research Institute - Sarasota Cattlemen Sarasota, Florida, United States
  • NEXT Dallas Irving, Texas, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Yale Cancer Center New Haven, Connecticut, United States
View Trial Details
Recruiting

Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Gastric or Esophageal Cancer.

NCT07217704

Conditions
Digestive System Diseases, Digestive System Neoplasms, Esophageal Cancer, +11 more
Locations
  • Helios CR Inc./RadNet Cerritos, California, United States
  • City of Hope National Cancer Center Duarte, California, United States
  • Hoag Memorial Hospital Irvine, California, United States
  • UCLA Los Angeles, California, United States
View all 16 locations
View Trial Details

Related conditions